Patents by Inventor Andrew D. Bergemann

Andrew D. Bergemann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibodies to the pur protein
    Patent number: 5869622
    Abstract: The present invention relates to the PUR protein, nucleotide sequences and expression vectors encoding PUR, and to methods for inhibiting PUR activity. More specifically, the invention relates to polyclonal and monoclonal antibodies that bind PUR or PUR related proteins. Antibodies that bind PUR protein and which neutralize. PUR activity may be used to treat hyperproliferative diseases such as cancer.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: February 9, 1999
    Assignee: Mount Sinai School of Medicine of the City University of New York
    Inventors: Edward M. Johnson, Andrew D. Bergemann
  • Cloning and expression of PUR protein
    Patent number: 5756684
    Abstract: The present invention relates to the PUR protein, nucleotide sequences and expression vectors encoding PUR, and to methods for inhibiting PUR activity. Inhibitors of PUR activity may be used to treat hyperproliferative diseases such as cancer.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: May 26, 1998
    Assignee: Mount Sinai School of Medicine of the City of New York
    Inventors: Edward M. Johnson, Andrew D. Bergemann
  • Methods for identifying compounds that bind to PUR protein
    Patent number: 5672479
    Abstract: The present invention relates to the PUR protein, nucleotide sequences and expression vectors encoding PUR, and to methods for inhibiting PUR activity. Inhibitors of PUR activity may be used to treat hyperproliferative diseases such as cancer.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 30, 1997
    Assignee: Mount Sinai School of Medicine
    Inventors: Edward M. Johnson, Andrew D. Bergemann